Is XBIOW or RYLD a better dividend investment in 2026?

XBIOW currently yields 11.40% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between XBIOW and RYLD?

XBIOW has a forward dividend yield of 11.40% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 0.74 percentage points.

Home › Compare › XBIOW vs RYLD

XBIOW vs RYLD: Dividend Comparison 2026

XBIOW yields 11.40% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $2.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XBIOW

● Live price

11.40%

Share price

$17.54

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42.5K

Annual income

$2,326.31

Full XBIOW calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — XBIOW vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XBIOW	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XBIOW + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XBIOW pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBIOW

Annual income on $10K today (after 15% tax)

$969.21/yr

After 10yr DRIP, annual income (after tax)

$1,977.36/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $221.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBIOW + RYLD for your $10,000?

XBIOW: 50%RYLD: 50%

100% RYLD50/50100% XBIOW

Portfolio after 10yr

$43.5K

Annual income

$2,456.83/yr

Blended yield

5.65%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBIOW buys

RYLD buys

No recent congressional trades found for XBIOW or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXBIOWRYLD

Forward yield	11.40%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$42.5K	$44.5K ✓
Annual income after 10y	$2,326.31	$2,587.35 ✓
Total dividends collected	$17.2K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: XBIOW vs RYLD ($10,000, DRIP)

Year	XBIOW Portfolio	XBIOW Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,840	$1,140.25	$11,914	$1,213.65	$74.00 → RYLD
2	$13,931	$1,261.76	$14,099	$1,351.30	$168.00 → RYLD
3	$16,293	$1,387.43	$16,580	$1,494.55	$287.00 → RYLD
4	$18,951	$1,516.57	$19,384	$1,642.61	$433.00 → RYLD
5	$21,926	$1,648.49	$22,535	$1,794.70	$609.00 → RYLD
6	$25,243	$1,782.51	$26,063	$1,950.00	$820.00 → RYLD
7	$28,928	$1,917.94	$29,995	$2,107.69	$1.1K → RYLD
8	$33,007	$2,054.14	$34,361	$2,266.99	$1.4K → RYLD
9	$37,508	$2,190.46	$39,194	$2,427.12	$1.7K → RYLD
10	$42,460	$2,326.31	$44,525	$2,587.35	$2.1K → RYLD

XBIOW vs RYLD: Complete Analysis 2026

XBIOW — Stock

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Full XBIOW Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this XBIOW vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBIOW vs SCHD XBIOW vs JEPI XBIOW vs O XBIOW vs KO XBIOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.